In conclusion, our findings highlight MDM4 as a critical regulator of ferroptosis in p53-mutant colon cancer, offering insights into potential therapeutic strategies targeting MDM4 and ferroptosis pathways to improve outcomes for patients with this challenging disease. This evidence concerns the gene TP53 and colonic neoplasm.